<?xml version="1.0" encoding="UTF-8"?>
<p id="p0220">Galidesivir is an adenosine analog that was initially developed to treat HCV, and its efficacy against Yellow fever revealed its antiviral activity in preclinical studies against many RNA viruses, including SARS-CoV and MERS-CoV 
 <xref rid="b0355" ref-type="bibr">[71]</xref>. At present, it is in primary clinical trials to assess its safety in healthy individuals. So, it might be useful against SARS-CoV-2.
</p>
